Raymond James & Associates’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.98M | Sell |
76,855
-3,884
| -5% | -$504K | 0.01% | 1235 |
|
|
2024
Q2 | $7.01M | Buy |
80,739
+6,283
| +8% | +$545K | ﹤0.01% | 1362 |
|
|
2024
Q1 | $8.17M | Buy |
74,456
+27,437
| +58% | +$3.01M | 0.01% | 1272 |
|
|
2023
Q4 | $4.93M | Sell |
47,019
-20,407
| -30% | -$2.14M | ﹤0.01% | 1539 |
|
|
2023
Q3 | $7.08M | Buy |
67,426
+1,984
| +3% | +$208K | 0.01% | 1249 |
|
|
2023
Q2 | $8.41M | Buy |
65,442
+2,209
| +3% | +$284K | 0.01% | 1156 |
|
|
2023
Q1 | $11M | Buy |
63,233
+5,102
| +9% | +$891K | 0.01% | 973 |
|
|
2022
Q4 | $9.66M | Buy |
58,131
+11,693
| +25% | +$1.94M | 0.01% | 1014 |
|
|
2022
Q3 | $6.54M | Buy |
46,438
+1,719
| +4% | +$242K | 0.01% | 1201 |
|
|
2022
Q2 | $9.12M | Buy |
44,719
+10,022
| +29% | +$2.04M | 0.01% | 1032 |
|
|
2022
Q1 | $8.84M | Buy |
34,697
+4,656
| +15% | +$1.19M | 0.01% | 1135 |
|
|
2021
Q4 | $9.86M | Buy |
30,041
+3,792
| +14% | +$1.24M | 0.01% | 1117 |
|
|
2021
Q3 | $7.94M | Buy |
26,249
+7,266
| +38% | +$2.2M | 0.01% | 1191 |
|
|
2021
Q2 | $5.15M | Buy |
18,983
+3,185
| +20% | +$864K | ﹤0.01% | 1477 |
|
|
2021
Q1 | $3.85M | Buy |
15,798
+4,486
| +40% | +$1.09M | ﹤0.01% | 1595 |
|
|
2020
Q4 | $3.24M | Buy |
11,312
+598
| +6% | +$171K | ﹤0.01% | 1585 |
|
|
2020
Q3 | $2.73M | Buy |
10,714
+1,992
| +23% | +$507K | ﹤0.01% | 1564 |
|
|
2020
Q2 | $1.89M | Buy |
+8,722
| New | +$1.89M | ﹤0.01% | 1763 |
|